France· FR:67324714
ETHINYLESTRADIOL/DROSPIRENONE BGRCONTINU 0,02 mg/3 mg, comprimé pelliculé
A medicinal product containing éthinylestradiol + drospirénone, registered in France by BIOGARAN.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉTHINYLESTRADIOL + DROSPIRÉNONE
- Manufacturer
- BIOGARAN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009301873711 plaquette(s) PVC PVDC aluminium de 28 comprimé(s) (21 comprimés actifs + 7 comprimés placebo)
- cip1334009301873883 plaquette(s) PVC PVDC aluminium de 28 comprimé(s) (21comprimés actifs + 7 comprimés placebo)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Éthinylestradiol + drospirénone in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABELLAARDEZ Pharma, spol. s r.o., Kosoř
- SpainAIDRA 3 MG/0,03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Cinfa S.A.
- PolandAsubtelaInPharm Sp. z o.o.
- FinlandCleodetteActavis Group PTC ehf
- NetherlandsBaradly 0,03 mg/3 mg filmomhulde tablettenHemony Pharmaceutical Germany GmbH
- United KingdomAcondro 0.03mg/3mg tabletsViatris UK Healthcare Ltd
- GermanyAidaBayer Vital Gmbh
- SwitzerlandEloine, FilmtablettenBerlis AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aliane, Danselle 21
- Belgium · Annaïs 20, Annaïs 30 Ceres Pharma
- Bulgaria · Жанги, Крипинео
- Cyprus · Yasmin, Yasminelle
- Czechia · Abella, Cris
- Germany · Aida, Drospifem 20
- Denmark · Asubtela, Etindros 21
- Estonia · Jangee, Madeleine
- Spain · Aidra, Aidraelle
- Finland · Diza, Midiana
- United Kingdom (Northern Ireland) · Dretine, Ellanite
- Greece · Estrofix, Yasmin
- Croatia · Crypineo, Rosanne
- Hungary · Altforalle, Aranka
- Ireland · Dretine, Dretinelle
- Iceland · Asubtela, Yasmin
- Italy · Calindir, Cris
- Lithuania · Edrocont, Etindros
- Luxembourg · Annaïs 20 Ceres Pharma, Annaïs 30 Ceres Pharma
- Latvia · Etindros, Midiana
- Malta · Edrocont, Freedonel
- Netherlands · Baradly, Belanette
- Norway · Calima, Diza
- Poland · Asubtela, Axia
- Portugal · Aranka, Arankelle
- Romania · Yasmin
- Sweden · Diza, Maitalon
- Slovenia · Crypineo, Daylla
- Slovakia · Daylla, Emie
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c501137b-5b24-419e-bea6-4fda68c674cf GET /v1/drugs/c501137b-5b24-419e-bea6-4fda68c674cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67324714",
"date_amm": "2019-07-31",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "ÉTHINYLESTRADIOL + DROSPIRÉNONE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé et comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about éthinylestradiol + drospirénone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.